Profound Medical (TSE:PRN) Reaches New 12-Month Low – Should You Sell?

Profound Medical Corp. (TSE:PRN) shares hit a new 52-week low during trading on Thursday . The stock traded as low as C$6.23 and last traded at C$6.31, with a volume of 600 shares. The stock had previously closed at C$6.34.

Profound Medical Stock Performance

The company has a current ratio of 6.12, a quick ratio of 14.98 and a debt-to-equity ratio of 20.05. The company has a 50-day moving average of C$9.14 and a 200-day moving average of C$10.11. The firm has a market capitalization of C$15.10 million, a price-to-earnings ratio of -3.28 and a beta of 1.19.

Insider Activity at Profound Medical

In other news, Director Arun Menawat Dr. bought 14,200 shares of Profound Medical stock in a transaction on Friday, March 14th. The stock was purchased at an average cost of C$10.09 per share, with a total value of C$143,319.75. Insiders own 8.62% of the company’s stock.

Profound Medical Company Profile

Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops and markets incision-free therapeutic systems for the image guided ablation of diseased tissue in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system combines magnetic resonance imaging(MRI), robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to provide precise, flexible, and durable ablation of a surgeon defined region of prostate and protect the urethra and rectum.